Convatec Shares Drop 8 Percent on Higher Cost Warning
British medical products maker Convatec reported slower organic revenue growth of 1.6 percent for the first four months of 2026. CEO Jonny Mason warned that rising oil prices linked to the Iran conflict could double cost inflation to 6 percent in 2027, creating a 30 million dollar headwind.
Xurve View
Insights:
Xurve View
CONVATEC GROUP PLC, a British medical device maker, saw shares fall 8% after reporting slowing revenue growth and warning of rising geopolitical costs. The company posted 1.6% organic revenue growth for the first four months of 2026, down from 6.2% in the prior year. Energy-driven inflation on plastic-heavy production lines threatens margins despite maintained annual guidance.
